Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · page 10 of 37
The slide uses a structural biology visualization and two dose-response curves to establish bio-equivalence and differentiation.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 image 1/1 source-note 1/1 title 1/1
Components 5
line line illustration source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1